The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takada, E.
Right arrow Articles by Mizuguchi, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takada, E.
Right arrow Articles by Mizuguchi, J.
The Journal of Immunology, 2001, 166: 1641-1649.
Copyright © 2001 by The American Association of Immunologists

Prevention of Anti-IgM-Induced Apoptosis Accompanying G1 Arrest in B Lymphoma Cells Overexpressing Dominant-Negative Mutant Form of c-Jun N-Terminal Kinase 11

Eiko Takada, Hiroko Toyota, Jun Suzuki and Junichiro Mizuguchi2

Department of Immunology and Intractable Disease Research Center, Tokyo Medical University, Tokyo, Japan

A family of mitogen-activated protein (MAP) kinases comprising the extracellular signal-regulated kinases (ERKs), c-Jun N-terminal kinases (JNKs), and p38 MAP kinases are involved in proliferation and apoptosis. However, there are some arguments concerning the role of these kinases in Ag-induced B cell apoptosis. Two of the B lymphoma cell lines (CH31 and WEHI-231) susceptible to anti-IgM-induced apoptosis were used as a model. To address these issues, we examined the kinetics of anti-IgM-induced activation of MAP kinases and established cell lines overexpressing a dominant-negative (dn) mutant form of JNK1 (dnJNK1). Anti-IgM induced a sustained JNK1 activation with a peak at 8 h, with a marginal activation of ERK1/ERK2 in CH31 cells. The sustained JNK1 activation was not a secondary event through a caspase activation. The peak point of the JNK1 activation was just before the onset of a decline in mitochondrial membrane potential, which preceded anti-IgM-induced cell death. Following anti-IgM stimulation, dnJNK1 prevented a decline in mitochondrial membrane potential at 24 h, with a prolonged inhibition up to 72 h in WEHI-231, although it did so only partially during a later time period in CH31. The dnJNK1 cells also demonstrated diminished procaspase-3 activation and a decreased rate of apoptosis upon anti-IgM stimulation, with a concomitant increased arrest in G1 phase, which could be explained by enhanced levels of cyclin-dependent kinase inhibitor p27Kip1 protein. Thus, anti-IgM-induced JNK activation might be implicated in cell cycle progression as well as in apoptosis regulation, probably involving p27Kip1 protein.




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. von Montfort, J. I. Beier, L. Guo, J. P. Kaiser, and G. E. Arteel
Contribution of the sympathetic hormone epinephrine to the sensitizing effect of ethanol on LPS-induced liver damage in mice
Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1227 - G1234.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. T. Tian, G. Gonzalez, B. Scheer, and A. L. DeFranco
Bcl10 can promote survival of antigen-stimulated B lymphocytes
Blood, September 15, 2005; 106(6): 2105 - 2112.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. R. Herrin, A. L. Groeger, and L. B. Justement
The Adaptor Protein HSH2 Attenuates Apoptosis in Response to Ligation of the B Cell Antigen Receptor Complex on the B Lymphoma Cell Line, WEHI-231
J. Biol. Chem., February 4, 2005; 280(5): 3507 - 3515.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Hata, T. Yoshimoto, and J. Mizuguchi
CD40 Ligand Rescues Inhibitor of Differentiation 3-Mediated G1 Arrest Induced by Anti-IgM in WEHI-231 B Lymphoma Cells
J. Immunol., August 15, 2004; 173(4): 2453 - 2461.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A.-K. Yi, J.-G. Yoon, and A. M. Krieg
Convergence of CpG DNA- and BCR-mediated signals at the c-Jun N-terminal kinase and NF-{kappa}B activation pathways: regulation by mitogen-activated protein kinases
Int. Immunol., May 1, 2003; 15(5): 577 - 591.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Koteish, S. Yang, H. Lin, X. Huang, and A. M. Diehl
Chronic Ethanol Exposure Potentiates Lipopolysaccharide Liver Injury Despite Inhibiting Jun N-terminal Kinase and Caspase 3 Activation
J. Biol. Chem., April 5, 2002; 277(15): 13037 - 13044.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.